These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
576 related articles for article (PubMed ID: 22213796)
1. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796 [TBL] [Abstract][Full Text] [Related]
2. ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients. Sveen A; Ågesen TH; Nesbakken A; Meling GI; Rognum TO; Liestøl K; Skotheim RI; Lothe RA Clin Cancer Res; 2012 Nov; 18(21):6001-10. PubMed ID: 22991413 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108 [TBL] [Abstract][Full Text] [Related]
4. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer. Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222 [TBL] [Abstract][Full Text] [Related]
5. Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer. Lin YH; Friederichs J; Black MA; Mages J; Rosenberg R; Guilford PJ; Phillips V; Thompson-Fawcett M; Kasabov N; Toro T; Merrie AE; van Rij A; Yoon HS; McCall JL; Siewert JR; Holzmann B; Reeve AE Clin Cancer Res; 2007 Jan; 13(2 Pt 1):498-507. PubMed ID: 17255271 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer. Katoh H; Yamashita K; Wang G; Sato T; Nakamura T; Watanabe M Ann Surg Oncol; 2011 Sep; 18(9):2432-41. PubMed ID: 21369738 [TBL] [Abstract][Full Text] [Related]
7. Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. Salazar R; Roepman P; Capella G; Moreno V; Simon I; Dreezen C; Lopez-Doriga A; Santos C; Marijnen C; Westerga J; Bruin S; Kerr D; Kuppen P; van de Velde C; Morreau H; Van Velthuysen L; Glas AM; Van't Veer LJ; Tollenaar R J Clin Oncol; 2011 Jan; 29(1):17-24. PubMed ID: 21098318 [TBL] [Abstract][Full Text] [Related]
8. Molecular signature for lymphatic metastasis in colorectal carcinomas. Croner RS; Förtsch T; Brückl WM; Rödel F; Rödel C; Papadopoulos T; Brabletz T; Kirchner T; Sachs M; Behrens J; Klein-Hitpass L; Stürzl M; Hohenberger W; Lausen B Ann Surg; 2008 May; 247(5):803-10. PubMed ID: 18438117 [TBL] [Abstract][Full Text] [Related]
9. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer. Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981 [TBL] [Abstract][Full Text] [Related]
10. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas. Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer. Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850 [TBL] [Abstract][Full Text] [Related]
12. Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis. Lin MS; Huang JX; Zhu J; Shen HZ Hepatogastroenterology; 2012 Sep; 59(118):1687-90. PubMed ID: 22591645 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of perineural invasion in stages II and III colorectal cancer. Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129 [TBL] [Abstract][Full Text] [Related]
15. Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: immunohistochemistry using a new monoclonal antibody. Tokunaga Y; Nakagami M; Tokuka A; Ohsumi K Anticancer Res; 2003; 23(2C):1763-8. PubMed ID: 12820455 [TBL] [Abstract][Full Text] [Related]
16. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer. Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967 [TBL] [Abstract][Full Text] [Related]
17. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine. Tokunaga Y; Takahashi K; Saito T Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of colorectal cancers and extraction of discriminator gene signatures for personalized prediction of prognosis. Miyake M; Takemasa I; Matoba R; Tanino M; Niijima S; Ikeda M; Yamamoto H; Sekimoto M; Kuhara S; Okayama T; Monden M; Matsubara K; Mori M Int J Oncol; 2011 Oct; 39(4):781-9. PubMed ID: 21701771 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer. Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223 [TBL] [Abstract][Full Text] [Related]